Literature DB >> 3959531

Colonization of Syrian hamsters with streptomycin resistant Campylobacter jejuni.

J G Fox, S Zanotti, H V Jordan, J C Murphy.   

Abstract

A streptomycin resistant Campylobacter jejuni inoculated per os into two populations of Syrian hamsters (one endemically harboring C. jejuni, the other free of C. jejuni) established chronic colonization of the organism in both groups. Diet, steroid administration, age of hamsters or prior exposure to C. jejuni did not appreciably alter incidence of diarrhea or colonization of C. jejuni. The majority of hamsters sampled during the course of the experiment (1 to 22 weeks) shed streptomycin resistant C. jejuni in the feces. In four hamsters sampled at 14, 17, 19, and 22 weeks, post inoculation, streptomycin resistant C. jejuni were recovered in ileal, cecal, jejunal, duodenal and colonic contents (10(4) to 10(7) colony forming units/gram of intestinal content). The hamster appears to be a potentially useful model for the study of intestinal colonization of enteropathogenic C. jejuni. Hamsters shedding C. jejuni in their feces for extended periods of time should be considered a zoonotic threat to both pet owners and laboratory personnel.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3959531

Source DB:  PubMed          Journal:  Lab Anim Sci        ISSN: 0023-6764


  3 in total

1.  Isolation of an intracellular bacterium from hamsters (Mesocricetus auratus) with proliferative ileitis and reproduction of the disease with a pure culture.

Authors:  H F Stills
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

2.  Experimental production of proliferative ileitis in Syrian hamsters (Mesocricetus auratus) by using an ileal homogenate free of Campylobacter jejuni.

Authors:  H F Stills; R R Hook
Journal:  Infect Immun       Date:  1989-01       Impact factor: 3.441

3.  Campylobacter jejuni colonization is associated with a dysbiosis in the cecal microbiota of mice in the absence of prominent inflammation.

Authors:  Abdul G Lone; L Brent Selinger; Richard R E Uwiera; Yong Xu; G Douglas Inglis
Journal:  PLoS One       Date:  2013-09-16       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.